Effect of Vitamin D on the Size of Fibroids in Women With Vitamin D Deficiency

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-09

Study Completion Date

2024-12-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vitamin D supplementation in patients with uterine fibroids who present hypovitaminosis D to re-establish their normal serum values could stabilize the size of the uterine fibroids and thus prevent their growth or reduce their size thanks to the anti-proliferative action of Vitamin D on the myoma cells.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Association Between Vitamin D and the Development of Uterine Fibroids

NCT03584529

Gynaecological Disease Vitamin D Deficiency

UNKNOWN NA

Vitamin D Deficit in Women With Uterine Fibroids

NCT04030182

Leiomyoma Vitamin D Deficiency Fibroid Uterus

COMPLETED

Association Between Vitamin D and the Risk of Uterine Fibroids

NCT03586947

Gynaecological Disease Vitamin D Deficiency Uterine Fibroids

UNKNOWN NA

Effect of Vitamin D3 Supplementation on Symptomatic Uterine Fibroid in Women With Vitamin D Deficiency

NCT07012161

Symptomatic Uterine Fibroid

RECRUITING EARLY_PHASE1

Vitamin D Levels And Myoma Uteri

NCT03871868

Myoma;Uterus Vitamin D Deficiency Polycystic Ovary

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Size of the Uterine Fibroids

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with at least one fibroid \> 3 cm
* With hypovitaminosis D (25(OH)D \< 30 ng/ml)
* BMI \< 30
* No hormonal treatment in the 3 months prior to the ultrasound study

Exclusion Criteria

* Black race
* Symptomatic fibroids subsidiary to hormonal or surgical treatment
* Desire of gestation in the next 6 months
* Presence of degenerating adenomyosis or fibroids
* Treatment with sexual hormones: mifepristone, aGnRH or any other medication that may interfere with fibroids.
* History of neoplasia of gynecological origin and/or existence of uterine malformations.
* Hypercalcemia or abnormal liver or kidney function is present

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No